This is to notify all that we have begun joint clinical research into nematode cancer detection (N-NOSE) of primary hepatic cancer, together with Tokyo University.
Regarding N-NOSE, both parties are considering whether it is possible to predict the effects of surgery, postoperative recurrence, and the prognosis by evaluating and reviewing the treatment of primary hepatic cancer and the progress following said treatment.
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .
2023.08.22Hirotsu Bio Science Inc. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Takaaki Hirotsu) has signed a memorandum of understanding wi . . .
2023.06.13On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .
2023.03.20